These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11931421)

  • 1. Periodic or routine susceptibility testing in tuberculosis control.
    Kalk A
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):176-7; author reply 177-9. PubMed ID: 11931421
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug resistance in pulmonary tuberculosis in Istanbul.
    Kilicaslan Z; Albal H; Kiyan E; Aydemir N; Seber E
    Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):763-4. PubMed ID: 12415480
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999.
    Crudu V; Arnadottir T; Laticevschi D
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of tuberculosis control by periodic or routine susceptibility testing in previously treated cases.
    Van Deun A; Salim AH; Rigouts L; Rahman M; Fissette K; Portaels F
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):329-38. PubMed ID: 11334251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tuberculosis drug resistance in Dohuk, Iraq.
    Merza MA; Farnia P; Masjedi MR; Ridell M
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1213-4. PubMed ID: 20819274
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention.
    Almeida D; Rodrigues C; Udwadia ZF; Lalvani A; Gothi GD; Mehta P; Mehta A
    Clin Infect Dis; 2003 Jun; 36(12):e152-4. PubMed ID: 12802779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic drug susceptibility testing: a necessary component of the 'DOTS plus' strategy?
    Grosset PJ
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):549-50. PubMed ID: 10423215
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in drug-resistant tuberculosis.
    Ghoshal AG; Mukherjee K
    J Assoc Physicians India; 1994 Apr; 42(4):348. PubMed ID: 7860576
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
    Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
    Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis.
    Garner P; Holmes A
    Clin Evid; 2002 Jun; (7):747-56. PubMed ID: 12230701
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of primary drug resistant tuberculosis.
    Jeyakumar D
    Med J Malaysia; 2000 Mar; 55(1):129-31. PubMed ID: 11072497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance monitoring: combined rates may be the best indicator of programme performance.
    Van Deun A; Salim AH; Daru P; Das AP; Aung KJ; Hossain MA; Rigouts L; Fissette K; Portaels F
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):23-30. PubMed ID: 14974742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.